Craig A Wheeler is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 16,483 shares of APLS, which is worth approximately $316,638. The most recent transaction as insider was on Apr 17, 2025, when has been sold 16,483 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K
n/a 3M change
n/a 12M change
Total Value Held $316,638

CRAIG A WHEELER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 17 2025
BUY
Grant, award, or other acquisition
-
16,483 Added 50.0%
16,483 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
CAW

Craig A Wheeler

Director
Philadelphia, PA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS